Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae

Tony Velkov1, Zakuan Z Deris, Johnny X Huang

  • 11Drug Development and Innovation, Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.

Innate Immunity
|July 27, 2013
PubMed

Insights

Klebsiella pneumoniae resistant to polymyxins B and colistin alters its outer membrane. This prevents the initial electrostatic binding of these antibiotics, rendering them ineffective against resistant strains.

Area of Science:

  • Microbiology
  • Bacterial Outer Membrane Studies
  • Antibiotic Resistance Mechanisms

Background:

  • Polymyxins B and colistin are crucial last-resort antibiotics.
  • Mechanisms of polymyxin resistance in Klebsiella pneumoniae are not fully understood.
  • Understanding resistance is vital for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the interaction of polymyxins with susceptible and resistant Klebsiella pneumoniae strains.
  • To elucidate the molecular basis of polymyxin resistance in K. pneumoniae.
  • To compare the outer membrane properties of wild-type and resistant strains.

Main Methods:

  • Utilized N-phenyl-1-naphthylamine (NPN) uptake assays.
  • Performed fluorometric binding and thermal shift assays.
  • Conducted lysozyme and deoxycholate sensitivity assays, zeta potential measurements, and (1)H NMR.

Main Results:

  • Resistant K. pneumoniae LPS showed reduced binding affinity for polymyxins B and colistin.
  • Outer membrane permeability increased in the resistant strain.
  • Polymyxins failed to permeabilize the resistant strain's outer membrane, unlike the wild-type.

Conclusions:

  • Resistant K. pneumoniae blocks the initial electrostatic binding of polymyxins.
  • This blockade renders the subsequent hydrophobic interactions of polymyxins ineffective.
  • Outer membrane modifications are key to polymyxin resistance in K. pneumoniae.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...